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Abstract
Background: Signal transducer and activator of transcription (STAT) proteins are key regulators
of gene expression in response to the interferon (IFN) family of anti-viral and anti-microbial
cytokines. We have examined the genomic relationship between STAT1 binding and regulated
transcription using multiple tiling microarray and chromatin immunoprecipitation microarray
(ChIP-chip) experiments from public repositories.
Results: In response to IFN-γ, STAT1 bound proximally to regions of the genome that exhibit
regulated transcriptional activity. This finding was consistent between different tiling microarray
platforms, and between different measures of transcriptional activity, including differential binding
of RNA polymerase II, and differential mRNA transcription. Re-analysis of tiling microarray data
from a recent study of IFN-γ-induced STAT1 ChIP-chip and mRNA expression revealed that
STAT1 binding is tightly associated with localized mRNA transcription in response to IFN-γ. Close
relationships were also apparent between STAT1 binding, STAT2 binding, and mRNA transcription
in response to IFN-α. Furthermore, we found that sites of STAT1 binding within the Encyclopedia
of DNA Elements (ENCODE) region are precisely correlated with sites of either enhanced or
diminished binding by the RNA polymerase II complex.
Conclusion: Together, our results indicate that STAT1 binds proximally to regions of the genome
that exhibit regulated transcriptional activity. This finding establishes a generalized basis for the
positioning of STAT1 binding sites within the genome, and supports a role for STAT1 in the direct
recruitment of the RNA polymerase II complex to the promoters of IFN-γ-responsive genes.
Background
Interferon-gamma (IFN-γ) is a potent pro-inflammatory
cytokine that regulates a spectrum of biological processes,
and is produced primarily in response to infection [1].
IFN-γ signal transduction begins at the cell surface with
the formation of a heteromeric protein complex that
includes IFN-γ, IFN-γ receptor-1, and IFN-γ receptor-2 [1].
Associated with the IFN-γ receptors are members of the
Janus kinase (JAK) family of tyrosine kinases, which
become activated upon formation of the IFN-γ receptor
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complex, and in turn phosphorylate the signal transducer
and activator of transcription-1 (STAT1) transcription fac-
tor [2-4]. Upon its phosphorylation, STAT1 homo-dimer-
izes, and is transported into the nucleus where it binds to
the gamma activated sequence (GAS; consensus: TTC-
NNNGAA [5]) to activate the expression of IFN-γ-respon-
sive genes [6]. One example of a STAT1-responsive gene is
the interferon regulatory factor-1 (IRF1) gene, an impor-
tant IFN-γ-responsive transcription factor which contains
a functional GAS 120 bp upstream of its first exon [7,8].
In addition, STAT1 functions as a component of the IFN
stimulated gene factor 3 (ISGF3) transcription factor com-
plex, which also includes STAT2 and interferon regulatory
factor-9 (IRF9) [9,10]. The ISGF3 complex is formed in
response to signaling by IFN family members, including
IFN-α, that associate with IFN-α receptor-1 and IFN-α
receptor-2. Upon its transportation into the nucleus,
ISGF3 binds to IFN-stimulated response elements (ISREs;
consensus: GGAAANNGAAACT [11]) to activate the
expression of IFN-α-responsive genes.
How gene expression is regulated by the association of
transcription factors to their target sequences is a central
question in mammalian biology. Compared with lower
organisms such as S. cerevisiae and D. melanogaster, the
genomic regions responsible for regulating the expression
of mammalian genes are much more difficult to predict,
and may be located far away from a gene's transcriptional
start site (TSS). Furthermore, the debate over what consti-
tutes a gene was further intensified with the development
of tiling arrays for the human genome, and the discovery
that much of the human transcriptome is coded for by
regions of the genome that lie outside of exons as they
have been classically defined [12,13]. Chromatin immu-
noprecipitation microarray (ChIP-chip) technology pro-
vided additional insight into the regulation of the human
transcriptome when it was employed to examine the tran-
scription factor binding sites (TFBSs) of Sp1, cMyc, and
p53 on chromosomes 21 and 22 [14]. Interestingly, only
22% of these TFBSs were located in the upstream regions
of genes, the regions that have classically been defined as
"promoter" regions. The genomic relationship between
sites of transcription factor binding, and sites of transcrip-
tion, was further elucidated in an elegant study of estrogen
receptor (ER) binding across chromosomes 21 and 22
[15]. Remarkably, the RNA polymerase II (RNApolII)
complex was found to associate in an estrogen-dependent
manner with the majority of tested TFBSs, even those
located far from the nearest TSS. Using a chromatin cap-
ture assay, an ER binding site located over 144 kbp from
the NRIP-1 gene was shown to function as an enhancer of
NRIP-1 transcription. These results showed that, when
bound to its TFBS, the ER can act as an enhancer to regu-
late the expression of target genes by associating, often
across large chromosomal distances, with RNApolII.
Recently, the response to IFN-γ has been the subject of
microarray expression analyses as well as ChIP-chip anal-
yses for STAT1 [16-20]. Hartman et al. compared the loca-
tions of STAT1 binding sites on chromosome 22 (as
determined by ChIP-chip) with the expression level of the
nearest gene, and noted that only 21% of STAT1 binding
sites were within 10 kbp of the start of the nearest gene.
Hartman et al. also suggested that a novel mechanism may
alter the specificity of STAT1 binding, depending on
whether it is induced by IFN-α or IFN-γ.
Elucidating the rationale with which transcription factor
binding sites are deployed across the genome will likely
be of great benefit to our understanding of the complexi-
ties of transcriptional regulation in mammals. We have
examined the data associated with several recent tiling
array experiments, and show here that STAT binding and
mRNA transcription in response to IFN are much more
closely associated than previous reports would suggest.
Our results indicate that, in contrast to other mammalian
transcription factors such as the ER, STAT1 binds closely
to the TSSs of its target genes. Our findings also suggest
that STAT1 may play an important role in recruiting the
RNApolII complex to the promoters of IFN-γ-inducible
genes.
Results
STAT1 binding and mRNA transcription in response to 
IFN-γ are correlated at the probe level for chromosome 22 
tiling arrays
To examine the relationship between STAT1 binding and
mRNA transcription in response to IFN-γ, we obtained the
data associated with Hartman et al.'s tiling array analysis
of gene transcription and STAT1 binding for chromosome
22 following treatment with IFN-γ and IFN-α [16]. We
were particularly interested in determining whether there
was any evidence for localized coupling of differential
STAT1 binding and differential mRNA expression. To our
surprise, there was a pronounced probe level correlation
between differential STAT1 binding in response to IFN-γ,
and differential mRNA expression in response to IFN-γ
(Figure 1A). A similar probe level relationship between
STAT1 binding, STAT2 binding, and differential expres-
sion, was also apparent for the responses of cells to IFN-α
(Figure 1B,C). Furthermore, probes that detected differen-
tial STAT2 binding in response to IFN-α also detected sub-
stantial differential expression in response to IFN-γ
(Figure 1D), and consistent with this, there was a high
probe level correlation between the binding of STAT1 or
STAT2 in response to IFN-α, and the binding of STAT1 in
response to IFN-γ (Figure 1E,F). Consistent with Hartman
et al.'s conclusion that the binding preference of STAT1
may differ in response to IFN-α versus IFN-γ [16], some
differences in the binding sites of STAT1 were apparent for
these stimuli (Figure 1E), although this was primarily trueBMC Genomics 2006, 7:254 http://www.biomedcentral.com/1471-2164/7/254
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Probe level relationships between STAT binding and mRNA transcription in response to IFN Figure 1
Probe level relationships between STAT binding and mRNA transcription in response to IFN. Differences in 
probe intensities for chromosome 22 arrays are plotted for the responses of HeLaS3 cells stimulated with IFN-γ or IFN-α (rel-
ative to non-stimulated controls). ∆STAT = differential STAT binding; ∆E = differential expression. (A) IFN-γ (∆E) vs IFN-γ 
(∆STAT1). (B) IFN-α (∆E) vs IFN-α (∆STAT1). (C) IFN-α (∆E) vs IFN-α (∆STAT2). (D) IFN-γ (∆E) vs IFN-α (∆STAT2). (E) 
IFN-γ (∆STAT1) vs IFN-α (∆STAT1). (F) IFN-γ (∆STAT1) vs IFN-α (∆STAT2). All raw data were obtained from Hartman et 
al.'s recent analysis of transcription and STAT binding in response to IFN [16]. All values are on the log2 scale. Red lines indi-
cate cutoffs of ± 0.5 (on the log2 scale).
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only of some of the relatively weak STAT1 binding sites.
For relatively strong STAT1 binding sites, the binding pref-
erences in response to IFN-γ versus IFN-α showed sub-
stantial correlation (Figure 1E).
The findings outlined above strongly suggest that there is
a high degree of overlap between the positions where
STAT1 and STAT2 bind in response to either IFN-γ or IFN-
α, which is perhaps not surprising, since STAT2 binds
DNA as part of the ISGF3 transcription factor complex, of
which STAT1 is also a component [10]. Consistent with
this, correlation was also apparent between the transcrip-
tional response of cells to IFN-γ and the transcriptional
response of cells to IFN-α (data not shown). Of greater
interest, however, is the clear probe level correlation
between the binding of STAT1 or STAT2, and the differen-
tial expression in response to IFN-γ or IFN-α. Given that
probes for the chromosome 22 arrays are 300 – 1400 bp
long [13], our observations indicate that the locations at
which STAT1 or STAT2 associate with chromosome 22 are
in the majority of cases very close to regions of chromo-
some 22 that are transcriptionally regulated by IFN-γ or
IFN-α.
Detection of STAT1 binding sites within the ENCODE 
region
To examine STAT1 binding in response to IFN-γ at a
higher resolution than is permitted by cDNA microarray
technology, we obtained data associated with a recent
ChIP-chip analysis of STAT1 binding in response to IFN-γ
[18] across the 1 Mb encyclopedia of DNA elements
(ENCODE) region [21]. A moderately conservative differ-
ential intensity cut-off of 20.4 (1.3-fold) was selected by
inspection of a quantile-quantile plot of the differential
intensities (data not shown). In total, 463 probes satisfied
this cut-off. These probes all clustered to 22 distinct
genomic sites, 17 (77%) of which were within 10 kbp of
the nearest 1st exon of a gene (Figure 3 and Table 1). This
method appears to identify fewer STAT1 binding sites
than are identified on the UCSC genome browser [22],
Distribution of STAT1 binding sites within the ENCODE region Figure 2
Distribution of STAT1 binding sites within the ENCODE region. Levels of differential STAT1 binding in response to 
IFN-γ (∆STAT1; black line) are plotted for ENCODE regions containing one or more probes exhibiting differential binding over 
a cut-off of 0.4 (red line). Probe intensities were smoothed as described in Methods. Arrows indicate locations and directions 
of known genes, and are colored to improve visual discrimination. All raw data were obtained from Rozowsky et al.'s tiling 
array analysis of STAT1 binding in response to IFN-γ [18]. Differential STAT1 binding values are on the log2 scale.BMC Genomics 2006, 7:254 http://www.biomedcentral.com/1471-2164/7/254
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STAT1 binding in response to IFN-γ is positively and negatively correlated with RNApolII binding Figure 3
STAT1 binding in response to IFN-γ is positively and negatively correlated with RNApolII binding. (A – N) Levels 
of differential STAT1 binding in response to IFN-γ (∆STAT1; black line) are plotted for locations within the ENCODE region 
where STAT1 binding sites (blue circles) were identified. Levels of RNApolII binding in non-stimulated HeLaS3 cells are shown 
in green ("0" corresponds to average RNApolII binding across the ENCODE region). Black boxes indicate the locations of 
exons; connecting lines indicate intronic regions; arrowheads within introns indicate the direction of transcription. Raw data 
were obtained from Rozowsky et al's tiling array analysis of STAT1 binding in response to IFN-γ [18], and Bieda et al.'s tiling 
array of RNApolII binding in non-stimulated cells [25].
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presumably because our significance cut-off is higher.
When the alternative transcripts of three genes, ATP11A,
MCF2L, and RAB11-FIP3, were accounted for, 21 of the 22
(95%) of the STAT1 binding sites we identified were
within 10 kbp of the nearest 1st exon of a gene (Table 1).
Of the 11 genes identified in this manner, three (IRF1,
PRKCG, and F7) are known IFN-γ-responsive genes
[7,8,23,24]. In the case of IRF-1, a STAT1 binding site
immediately upstream of the first exon has been previ-
ously identified by in vivo footprinting [7].
The majority of STAT1 binding sites exhibit localized 
suppression of RNApolII binding in non-stimulated cells
Our finding that IFN-γ-induced STAT1 binding to chro-
mosome 22 is closely associated with increased mRNA
transcription suggested that STAT1 may bind proximally
to RNApolII within the promoters of IFN-γ-responsive
genes. We were therefore interested in examining the
binding of RNApolII to regions near STAT1 binding sites.
To this end, we obtained data associated with Bieda et al.'s
recent analysis of RNApolII binding within the ENCODE
region for non-stimulated HeLaS3 cells [25]. Remarkably,
the binding of RNApolII in non-stimulated cells was neg-
atively correlated (on the log2 scale) with the binding of
STAT1 in response to IFN-γ for 17 of the 22 binding sites
within the ENCODE region (Figure 3A–I, K, L). This is
indicative of a diminished level of RNApolII binding, rel-
ative to the average level of RNApolII binding for the
entire ENCODE region. Localized suppression of
RNApolII binding is likely to reflect the locations at which
modifications in the chromatin state, or possibly other
factors, prevent the association of RNApolII (relative to
the average level of association across the ENCODE
region).
RNApolII binds to STAT1 binding sites near the IRF1 and 
IFNaR1 genes in non-stimulated cells
Of the five STAT1 binding sites that did not exhibit sup-
pressed RNApolII binding in non-stimulated cells (Figure
3J, M, N), three were located within 7 kbp upstream of the
IRF1 gene (Figure 3N), and one was located near the start
of the IFNaR1 gene (Figure 3M). In each case, STAT1 bind-
ing in response to IFN-γ was positively correlated with
RNApolII binding, relative to the average level of
RNApolII binding across the ENCODE region.
Binding of RNApolII and localized mRNA transcription are 
associated with STAT1 binding sites near the IRF1 and 
IFNaR1 genes in non-stimulated cells
Our finding that IFN-γ-induced STAT1 binding to chro-
mosome 22 is closely associated with increased mRNA
transcription indicated that STAT1 binds closely to tran-
scriptionally-active regions of the genome. Our subse-
quent identification of STAT1 binding sites that are bound
by RNApolII near the start positions of the IRF1 and
IFNaR1 genes in non-stimulated cells suggested that basal
Table 1: Distribution of STAT1 binding sites detected within the ENCODE region.
Chr Position Distance Gene symbol Description RefSeq id Figure
13 111381278 -6172 ATP11A* ATPase I type 11A BC024154 3A
111475471 +88021 (+1162) BC024154 (AK024264) 3B
13 111614528 +43712 (+9528) MCF2L* MCF.2-like NM_024979 (BC020208) 3C
111635357 +64541 (+30357) 3D
13 111659869 +48237 (-6750) F7 (MCF2L*) Coagulation factor VII precursor NM_000131 (AB116075) 3E
111710547 +2441 F7 NM_000131 3F
16 150458 -5539 HBM Hemoglobin mu chain (Hypothetical protein) NM_001003938 3G
16 176687 +6352 HBQ1 Hemoglobin theta-1 chain NM_005331 3H
16 457805 +42185 (-3412) Rab11-FIP3* Rab11 family-interacting protein 3 NM_014700 (BC009036) 3I
19 59084649 +7247 PRKCG Protein kinase C, gamma NM_002739 3J
19 59114793 +4154 - Ensembl predicted - 3K
59115225 +3722 gene
59116521 +2426 ENSG00000188966
59116611 +2336
59117115 +1832
59117619 +1328
59119491 -544
21 32879469 -1229 TCP10L t-complex 10 (mouse)-like NM_144659 3L
21 33523051 +376 IFNaR2 Interferon (alpha, beta and omega) receptor 2 NM_000874 3M
5 131902803 -160 IRF1 Interferon regulatory NM_002198 3N
131907429 -4786 factor-1
131908640 -5997
The genomic positions at which STAT1 binds in response to IFN-γ were determined by taking the average position of each peak of STAT1 binding 
with a score greater than 0.4, as described in Figure 2. Distances from the start sites of nearest genes are given in base-pairs (according to NCBIv34 
annotation). References to Figure 3, showing graphical illustrations of STAT1 binding intensities, are given for each STAT1 binding site.BMC Genomics 2006, 7:254 http://www.biomedcentral.com/1471-2164/7/254
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levels of mRNA transcription might be detectable at these
sites. To investigate this possibility, we obtained data
associated with a recent analysis of basal mRNA transcrip-
tion in non-stimulated HeLa cells for 10 human chromo-
somes [26]. Pleasingly, most exons of the IRF1 and
IFNaR1 genes exhibited clear peaks of basal mRNA detec-
tion (Figure 4A, B). Basal mRNA transcription was appar-
ent not only within exons, but also introns and extragenic
regions (Figure 4A, B). All peaks of STAT1 binding near
the IRF1 and IFNaR1 genes overlapped with peaks of basal
mRNA transcription as well as peaks of basal RNApolII
binding (Figure 4A, B), thus reinforcing our finding using
Hartman et al.'s chromosome 22 data [16] that STAT1
binding to chromosome 22 is closely associated with
increased mRNA transcription in response to IFN-γ.
STAT1 binds proximally to the start positions of genes with 
key roles in the cellular response to IFN-γ
When conducting microarray analyses of cellular
responses to stimuli, it is often difficult to distinguish
Detection of basal mRNA transcription near binding sites for STAT1 and RNApolII Figure 4
Detection of basal mRNA transcription near binding sites for STAT1 and RNApolII. The binding of STAT1 in 
response to IFN-γ was compared with the binding of RNApolII and the transcription of mRNA in non-stimulated cells. Black 
line (∆STAT1): log2 of differential STAT1 binding in cells stimulated with IFN-γ. Green line (∆RNApolII): log2 of differential 
RNApolII binding, relative to the average binding of RNApolII across the ENCODE region, in non-stimulated cells. Blue line 
(mRNA %max): percentage of maximum mRNA detection score across the window. Black boxes indicate the locations of 
exons; connecting lines indicate intronic regions; arrowheads within introns indicate the direction of transcription. (A) IRF1 
gene and upstream region. (B) IFNaR1 gene. Raw data were obtained from Rozowsky et al's tiling array analysis of STAT1 bind-
ing in response to IFN-γ [18], Bieda et al.'s tiling array of RNApolII binding in non-stimulated cells [25], and Sekinger et al.'s til-
ing array analysis of polyA RNA levels in non-stimulated cells [37].
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genes that are obligatory components of the cell's
response from genes that are induced only in particular
cell types or under certain conditions, and may therefore
be less critical to the outcome of the response. It is inter-
esting to note that within the ENCODE region, STAT1
bound most closely to start positions of two genes with
key roles in IFN signal transduction, IRF1 and IFNaR2
(Table 1). In fact, these are the only genes for which prox-
imal STAT1 binding in the ENCODE region was observed
that have known roles in IFN signal transduction. We
wondered therefore whether STAT1 binding sites are also
closely associated with the start positions of other "key"
IFN-γ-inducible genes. To this end, we identified 10 genes
for which the transcriptional response to IFN-γ is con-
served between human microglial cells and mouse livers,
and are thus likely to be essential components of the
responses of most cells to IFN-γ (Table 2). Remarkably,
the expression levels of seven of these genes are known to
be regulated by STAT1 binding sites located within just
200 bp of the start of each gene (Table 2). This close prox-
imity with which STAT1 regulates the expression of key
IFN-γ-responsive genes is in stark contrast to the relatively
large distances between most STAT1 binding sites within
the ENCODE region, and the start positions of the nearest
genes (Table 1). This suggests that genes with STAT1 bind-
ing sites that are not located close to the start of the coding
region could be more susceptible to tissue-specific mech-
anisms of regulation, for example by chromatin modifica-
tion of the promoter.
Discussion
Whilst it is clear that mammalian promoter regions are
often enriched for TFBSs, much remains to be learnt about
how mammalian TFBSs are distributed throughout the
genome, and what determines the positioning of TFBSs.
We analyzed data from Hartman et al.'s study of IFN-
induced STAT binding and mRNA transcription for chro-
mosome 22 [16], and to our surprise, we observed a
marked probe level correlation between STAT1 binding
and differential expression in response to IFN-γ. Although
all ChIP-chip analyses of transcription factor binding have
the potential to detect some RNApolII binding sites due to
interactions between RNApolII and the transcription fac-
tor of interest, our results suggest that the vast majority of
STAT1 binding sites, if not all STAT1 binding sites, are
proximal to transcriptionally active regions. The extent to
which we observed this phenomenon indicates that
STAT1 binding sites are located proximally to regions that
are bound by the transcriptional apparatus.
In addition to the discovery of a probe level correlation
between mRNA transcription and STAT1 binding in
response to IFN-γ, our analysis of Hartman et al.'s Chro-
mosome 22 tiling array data for STAT binding and mRNA
transcription in response to IFN [16] revealed probe level
correlations for various combinations of STAT1 binding,
STAT2 binding, and mRNA transcription in response to
treatment with either IFN-γ or IFN-α. Together, these
observations suggest that differences in the binding specif-
icities between STAT1 and STAT2 are predominantly
quantitative rather than qualitative. Consistent with this
idea, IFN-α and IFN-γ were recently shown to induce the
transcription of similar sets of genes [20]. The substantial
correlation we observed between the binding sites of
STAT1 in response to IFN-α vs IFN-γ perhaps casts some
doubt over the significance of Hartman et al.'s observation
that the binding preference of STAT1 is differentially reg-
ulated in response to IFN-α as compared to IFN-γ [16].
Table 2: Genes induced by IFN-γ in both human and mouse tissues, and associated STAT1 binding sites.
Gene Symbol Description STAT1 TFBS Reference
BCL6 B-cell leukemia/lymphoma-6 +192 bp [43]
CXCL10 Chemokine (C-X-C motif) ligand-10 -153 bp [44]
CXCL9 Chemokine (C-X-C motif) ligand-9 -167 bp [45-47]
GADD45γ Growth arrest and DNA-damage-inducible 45 gamma unknown
ID2 Inhibitor of DNA binding-2 unknown
IRF1 Interferon regulatory factor-1 -120 bp [7]
IFIT2 Interferon-induced protein with tetratricopeptide repeats-2 -85 bp [48]
SOCS1 Suppressor of cytokine signalling-1 unknown
SOCS3 Suppressor of cytokine signalling-3 -64 bp [49]
TAP1 Transporter 1, ATP-binding cassette, sub-family B +135 bp [50]
Genes exhibiting significant (p < 0.01) differential expression in human microglial cells stimulated with IFN-γ for 1 h were identified by limma [34, 
42] analysis of data associated with Rock et al.'s recent publication [17] (GEO id GSE1432). 80 orthologous mouse genes were identified using 
HCNetDat [51]. Differential expression levels in response to IFN-γ for the orthologous mouse genes were determined by affy [38-40] analysis of 
data associated with our recent publication of transcriptional responses to IFN-γ in IFN-γ-/- mouse livers [19] (GEO id GSE4232). Literature was 
searched for experimentally verified STAT1 TFBSs (either GAS sites or ISRE sites were accepted) associated with the 10 most differentially 
regulated orthologous mouse genes (each was induced over 1.6-fold). Positions of STAT1 binding sites are given relative to the start of the first 
exon of each gene.BMC Genomics 2006, 7:254 http://www.biomedcentral.com/1471-2164/7/254
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Consistent with our observation of a probe level correla-
tion between STAT1 binding and mRNA expression in
response to IFN-γ for Chromosome 22, we found that
STAT1 binds specifically to sites within the ENCODE
region that exhibit either diminished or enhanced bind-
ing of RNApolII in non-stimulated cells. Collectively,
these findings suggest that STAT1 binds proximally to
regions of the genome that are involved in the initiation
of RNA transcription, since this would explain both the
correlation with mRNA transcription that we identified
using the Chromosome 22 tiling array data, and the cor-
relation with differential RNA polymerase binding that we
identified using the ENCODE tiling array data. The pri-
mary mechanism by which STAT1 activates gene tran-
scription may therefore be to recruit RNA polymerase II to
the promoters of IFN-γ-responsive genes.
There have been several reports implicating STAT1 in the
recruitment of components of the transcriptional appara-
tus to the promoters of particular IFN-responsive genes. In
2003, STAT1 was shown to synergize with NF-κB at the
promoter of the CXCL9 gene to bind the transcriptional
co-activator, CREB-binding protein, which may in turn
recruit the RNApolII complex [27]. In 2004, it was shown
that IRF9 (a member of the ISGF3 complex) may recruit
the RNApolII complex to the promoter of interferon-stim-
ulated gene 54 in a histone deacetylase-dependent man-
ner [28]. In 2005, STAT1 was shown to recruit the DNA
helicase protein mini-chromosome maintenance-5 to the
promoters of the genes encoding IRF1, TAP1, guanylate-
binding protein-1, and class II transactivator in response
to IFN-γ [29]. Furthermore, transcription of the aforemen-
tioned genes in response to IFN-γ was dependent on the
activity of the mini-chromosome maintenance-5 protein,
and the binding of the mini-chromosome maintenance-5
protein to the IRF1 gene was consistent with the binding
of RNApolII to the IRF1 gene [29]. Our findings that
STAT1 binds to positions on chromosome 22 that exhibit
IFN-γ-inducible mRNA transcription, and to positions
within the ENCODE region that exhibit either enhanced
or diminished RNApolII binding (relative to the average
level of RNApolII binding), are in strong agreement with
the above reports. Furthermore, our results generalize the
findings of the previous reports, since they suggest that
recruitment of the RNApolII complex to the promoters of
IFN-γ-responsive genes is the dominant mechanism by
which STAT1 activates gene transcription. At STAT1 bind-
ing sites that are normally inaccessible to RNApolII, this
could involve chromatin modification to make the site
more accessible to RNApolII. At STAT1 binding sites that
exhibit basal levels of RNApolII binding, STAT1 may sim-
ply enhance RNApolII binding. Such a mechanism of
transcriptional regulation contrasts with that of the ER,
which can regulate the transcription of genes from distant
ER TFBSs by acting as an enhancer for RNApolII activity
[15].
Interestingly, two STAT1 binding sites upstream of two
well characterized mediators of IFN signal transduction,
IFNaR1 and IRF1, were the closest two STAT1 binding
sites to the start of any gene in the ENCODE region (both
were located less than 500 bp away). This could simply be
a coincidence, however our identification of ten genes for
which transcription in response to IFN-γ is conserved
between different tissues of humans and mice provides an
interesting alternative explanation. Whilst many genes are
probably induced by IFN-γ only in certain cell types or
under certain conditions, these ubiquitously-responsive
genes are likely to play key roles in the response to IFN-γ
of numerous cell types (just as IFNaR1 and IRF1 do). Con-
sistent with this hypothesis, genes with important func-
tions in cytokine signaling were identified, including
SOCS-1 and -3 [30], IRF1 [8], and the chemokines CXCL9
and CXCL10 [31]. Remarkably, seven of the ten ubiqui-
tously-IFN-γ-inducible genes that we identified are known
to be regulated by STAT1 binding sites that are located
within 200 bp from the start of each gene. Of the remain-
ing three, little is known about the roles of GADD45γ and
ID2 in response to IFN-γ, and SOCS-1 may be regulated
primarily by IRF1, and not STAT1 [19]. The close proxim-
ity with which STAT1 regulates the expression of "core"
IFN-γ-inducible genes suggests that many of the STAT1
binding sites identified by ChIP-chip may be involved in
the regulation of genes, alternative gene transcripts, or
non-coding RNAs that are induced by IFN-γ only in cer-
tain cell types or only under certain conditions. As illus-
trated in Figure 5, increased regulatory opportunities may
be available for genes that are regulated by STAT1 from a
distance, compared with genes that are regulated by
STAT1 close to the start of the coding region. This model
contrasts with a recent report showing that different com-
binations of transcription factor binding sites in the prox-
imal promoter region are important for determining
tissue-specific gene expression [32]. However, given that
biological systems are inherently variable, it seems
unlikely that the two models are necessarily mutually
exclusive.
Conclusion
Our analysis of STAT1 binding and mRNA transcription
reveals that the binding of STAT1 is closely associated with
IFN-γ-inducible transcriptional activity. Furthermore, our
findings implicate STAT1 in the regulation of RNApolII
binding, and suggest that recruitment of the RNApolII
complex to the promoters of IFN-γ-responsive genes could
be a general mechanism by which STAT1 activates tran-
scription. Finally, we propose that STAT1 may strategically
associate with the start positions of key IFN-γ-responsiveBMC Genomics 2006, 7:254 http://www.biomedcentral.com/1471-2164/7/254
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A hypothetical mechanism by which condition-specific or non-specific transcriptional responses to IFN-γ may be achieved Figure 5
A hypothetical mechanism by which condition-specific or non-specific transcriptional responses to IFN-γ may 
be achieved. (A – D) Condition-specific responsiveness to IFN-γ of a gene, "gene 1". Condition A: STAT1 ("S") and transcrip-
tion factor-X ("X") are inactive, and hence the binding sites for STAT1 (blue DNA) and X (yellow DNA) are unoccupied. In 
this state, chromatin-modifying proteins render regions near the binding sites for STAT1 and X (red DNA) inaccessible to 
RNApolII. Condition B: In this condition, STAT1 is activated by IFN-γ, and associates with its binding site upstream of gene 1. 
STAT1 recruits chromatin-modifying proteins ("?") to make the region accessible to RNApolII; STAT1 then recruits RNApolII 
to DNA near the STAT1 binding site. RNApolII is unable to transcribe gene 1, however, because the chromatin configuration 
near the binding site for X inhibits its progression. Condition C: In this condition, X is active, and associates with its binding site 
upstream of gene1 to recruit chromatin-modifying proteins, which make the region accessible to RNApolII. However, 
RNApolII is not actively recruited to the gene 1 promoter, so gene 1 is not transcribed. Condition D: In this condition, both 
STAT1 and X associate with their binding sites, and recruit chromatin-modifying proteins to make the promoter accessible to 
RNApolII. STAT1 then recruits RNApolII, and RNApolII is able to progress along the promoter to transcribe gene 1. (E) Non-
specific transcriptional responsiveness to IFN-γ of a gene, "gene 2". Gene 2 is regulated by transcription factors that associate 
with binding sites (blue, yellow and purple DNA) within its promoter. Gene 2 has a key role in regulating the response to IFN-
γ, so it is important that it is induced by IFN-γ in all tissues, under all conditions. The STAT1 binding site is therefore located 
close to the start of gene 2, where other regulatory elements within the promoter will not affect the ability of STAT1 to 
induce transcription of gene 2.
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genes to ensure that they are ubiquitously, rather than
conditionally, induced in response to IFN-γ.
Methods
Analysis of chromosome 22 cDNA tiling array data
Genepix files corresponding to Hartman et al.'s [16] anal-
ysis of STAT binding and mRNA transcription in response
to 120 min of IFN stimulation were obtained on-line [33].
All experiments were performed using HeLaS3 cells. These
cDNA tiling arrays are designed to detect chromosome 22
DNA using 300 – 1400 bp probes, which are aligned with
chromosome 22 in an end-to-end configuration [13]. The
complete set of chromosome 22 cDNA tiling arrays is
comprised of three different arrays, numbered 1 to 3 [13].
In all cases where plots of data from chromosome 22
arrays are presented here, the data correspond to array-2
of the three-array set, and are representative of arrays -1
and -3. Data from 4 – 6 replicates were analyzed for all
treatments. We processed and analyzed Genepix data
using the limma package [34] for the R statistical pro-
gramming environment, as follows. Background correc-
tion was performed using limma's "normexp" method.
Within-array normalization was achieved using print-tip
loess normalization. Between-array normalization was
achieved using quantile normalization of mean probe
intensity values, which is implemented by limma as the
"Aquantile" method. Correlations in probe intensity lev-
els ("probe level correlations") between different IFN
treatments, and between either mRNA transcription or
chromatin immunoprecipitation for STAT1, were visually
assessed using scatterplots. Probe intensity levels for IFN-
stimulated cells showed no correlation with NF-kappaB
binding in response to tumor necrosis factor-alpha [35],
indicating that the correlations observed are specific to the
response to IFN (data not shown).
Analysis of ENCODE oligonucleotide tiling array data
Cy5 and Cy3 probe intensity values for Rozowsky et al.'s
[18] 36-base oligonucleotide tiling array analysis of
STAT1 binding in HeLaS3 cells in response to 30 min of
IFN-γ stimulation were obtained from the Gene Expres-
sion Omnibus (GEO) website [36], series id GSE2714.
These data are also available as a track on the UCSC
genome browser [22]. Experiments were performed in
duplicate. These tiling arrays are designed to detect the 30
Mb Encyclopedia of DNA Elements (ENCODE) region
[21]. Probes are 36 bases in length, and are aligned with
DNA from the ENCODE region in an end-to-end configu-
ration. We used limma [34] to perform within-array nor-
malization (using the "loess" method) and quantile
normalization of mean probe intensity values (using the
"Aquantile" method). To enhance the identification of
runs of probes that detect STAT1 binding, probe intensi-
ties were smoothed by taking the mean intensites across a
window of 20 probes (720 bp).
Cy5 and Cy3 probe intensity values for Bieda et al.'s [25]
50-base oligonucleotide tiling array analysis of RNApolII
binding in non-stimulated HeLaS3 cells were obtained
from the Gene Expression Omnibus (GEO) website [36],
series id GSE4337. Experiments were performed in tripli-
cate. These tiling arrays are designed to detect the
ENCODE region [21]. Probes are 50 bases in length, and
are aligned with DNA from the ENCODE region in a 12-
base overlap configuration. We used limma [34] to per-
form between-array normalization (using the "loess"
method) and quantile normalization of mean probe
intensity values (using the "Aquantile" method). To
enhance the identification of runs of probes that detect
RNApolII binding, probe intensities were smoothed by
taking the mean intensites across a window of 20 probes
(760 bp). To perform probe level comparisons between
these 50-base oligonucleotide arrays, and the 36-base oli-
gonucleotide arrays for Rozowsky et al.'s [18] ChIP-chip
analysis of STAT1 binding within the ENCODE region,
probe intensities from the 50-base overlapping format
were mapped to the 36-base end-to-end format. Weighted
averages were calculated where two 50-base probes over-
lapped with a single 36-base probe.
Polyadenylated (polyA) RNA signal values for Sekinger et
al.'s [37] tiling array analysis of non-stimulated HeLaS3
cells were obtained from the GEO website, series id
GSE2800. The tiling arrays used for these experiments
were manufactured by Affymetrix (Santa Clara, CA), and
have 25 base probes that detect DNA from the ENCODE
region in a 5-base-overlap configuration. Signal values
were determined using the Wilcoxon Sign Rank Scan Sta-
tistic, as outlined in the description accompanying each
sample. To enhance the identification of runs of probes
that detect the presence of polyA RNA, we smoothed
probe intensity values by taking the mean intensity across
a window of 20 probes (400 bp).
Analysis of Affymetrix GeneChip expression data
Probe intensity values for Rock et al.'s microarray analysis
of the transcriptional response of human fetal microglial
cells to 1 h of IFN-γ treatment [17] were obtained from the
GEO website, series id GSE1432. All experiments were
performed in quadruplicate. Affymetrix GeneChip
HGU133A arrays, which detect the expression of approxi-
mately 16,000 human genes, were used for this experi-
ment. We used limma [34] to perform within-array
(loess) and between-array (quantile) normalization of
probe intensity data, and to identify significantly differen-
tially expressed genes.
Affymetrix MGU74Av2 CEL files for our previously
reported timecourse analysis of the transcriptional
response of IFN-γ-/- mouse livers to intraperitoneal injec-
tion with IFN-γ [19] (GEO series id GSE4232) were proc-BMC Genomics 2006, 7:254 http://www.biomedcentral.com/1471-2164/7/254
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essed by the affy package [38-40] for the R statistical
programming environment [41]. Background correction,
quantile normalization, and expression summaries were
performed using affy's "robust multiarray average"
method, with default parameters. Samples corresponding
to 0 h, 0.5 h, 1 h, 2 h, 4 h, 12 h, 16 h, 24 h and 48 h after
stimulation with IFN-γ were included in the analysis.
Data analysis
All analyses of data were carried out using the R statistical
programming environment[41]. Levels of differential
expression were determined by limma [34] using empiri-
cal Bayes statistics [42].
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